The seroprevalence of antibodies to Toxoplasma gondii among children with autism
Erman Esnafoglu, Esra Yancar Demir, Yeliz Cetinkol, Mustafa Kerem Calgin, Abdullah Erdil, Emine Yurdakul Erturk, Abdullah Dagli
Article No: 4   Article Type :  Research
Objective: Although attempts have been made to explain the pathogenesis of autism spectrum disorders (ASD) with many factors such as genetic, immunological, environmental, and infectious agents, this mechanism remains for the most part unknown. Toxoplasma gondii is a parasite that is investigated in many psychiatric diseases. This work examines whether toxoplasmosis plays a role in the pathogenesis of ASD through a seroprevalence study.

Method: This study is based on a comparison of 102 children with ASD and 51 healthy children. In addition to routine laboratory tests, a sociodemographic form and a childhood autism rating scale were completed and the participants’ anti-toxoplasma IgM and IgG titers were requested.

Results: In 3 ASD children (2.9%) and in 1 control (2%), IgG positivity was identified. All subjects were negative for IgM. There was no statistically significant difference found between the two groups in terms of toxoplasma seropositivity.

Conclusion: Our data does not confirm the involvement of toxoplasmosis in the etiopathogenesis of ASD.
Keywords : Autism, autism spectrum disorder, toxoplasmosis, Toxoplasma Gondii
Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2017;30:309-315
1. APA. Diagnostic and statistical manual of mental disorders, fifth edition. American Psychiatry Association, Washington, DC, 2013.

2. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009; 194:500-509. [CrossRef]

3. Lai MC, Lombardo MV, Baron-Cohen S . Autism. Lancet 2014; 383:896-910. [CrossRef]

4. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 2006; 80:1-15. [CrossRef]

5. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-1976. [CrossRef]

6. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 2009; 16:122-133. [CrossRef]

7. Al-Hussainy NH, Al-saedi AM, Al-lehaibi JH, Al-lehaibib YA, Al-Sehli YM, Afifi MA. Serological evidences link toxoplasmosis with schizophrenia and major depression disorder. Journal of Microscopy and Ultrastructure 2015; 3:148-153. [CrossRef]

8. Alvarado-Esquivel C, Urbina-Alvarez JD, Estrada-Martinez S, Torres-Castorena A, Molotla-de-Leon G, Liesenfeld O, Dubey JP. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int 2011; 60:151-155. [CrossRef]

9. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH, Postolache TT. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009; 197:905-908. [CrossRef]

10. Emelia O, Amal RN, Ruzanna ZZ, Shahida H, Azzubair Z, Tan KS, Noor Aadila S, Siti NA, Aisah MY. Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia. Trop Biomed 2012; 29:151-159.

11. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospevtive case-control study. BMC Infect Dis 2002; 2:11. [CrossRef]

12. Gale SD, Brown BL, Berrett A, Erickson LD, Hedges DW. Association between latent toxoplasmosis and major depression, generalised anxiety disorder and panic disorder in human adults. Folia Parasitol (Praha) 2014; 61:285-292. [CrossRef]

13. Hinze-Selch D, Daubener W, Erdag S, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) 2010; 57:129-135. [CrossRef]

14. Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011; 199:440-444. [CrossRef]

15. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res 2010; 177:263-265. [CrossRef]

16. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, Yolken RH. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61:688-693. [CrossRef]

17. Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 2011; 49:211-220.

18. Yagmur F, Yazar S, Temel HO, Cavusoglu M. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 2010; 199:15-17. [CrossRef]

19. Halonen SK, Weis LM. Toxoplasmosis. Handb Clin Neurol 2013; 114:125-145. [CrossRef]

20. Werner H, Masihi KN, Senk U. Latent toxoplasma-infection as a possible risk factor for CNS-disorders. Zentralbl Bakteriol Mikrobiol Hyg A 1981; 250:368-375.

21. Carter CJ. Toxoplasmosis and polygenic disease susceptibility genes: extensive toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Pathog 2013; 2013:965046. [CrossRef]

22. Thong YH. Reptilian behavioural patterns in chilhood autism. Med Hypotheses 1984; 13:399-405. [CrossRef]

23. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. PLoS One 2011; 6:e23866. [CrossRef]

24. Zhu S. Psychosis may be associated with toxoplasmosis. Med Hypothesis 2009; 73:799-801. [CrossRef]

25. Gillberg C, Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 1987; 151:89-94. [CrossRef]

26. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 2010; 67:59-68. [CrossRef]

27. Prandota J. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice. Res Autism Spectr Disord 2010; 4:103-118. [CrossRef]

28. Prandota J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Res Autism Spectr Disord 2010; 4:119-155. [CrossRef]

29. Sucuoglu B, Oktem F, Akkok F, Gokler B. A study about childhood autism scales. Psikiyatri, Psikoloji, Psikofarmakoloji (3P) Dergisi 1996; 4:116-121. (Turkish)

30. Afsharpaiman S, Skandari A, Maryam ZJ, Radfar S, Shirbazoo S, Amirsalari S, Torkaman M. An assessment of Toxoplasmosis antibodies seropositivity in children suffering Autism. Tehran University Medical Journal 2014; 72:106-112.

31. Prandota J, Elleboudy NAF, Ismail KA, Zaki OK, Shehata HH. Increased seroprevalence of chronic toxoplasmosis in autistic children: special reference to the pathophysiology of IFN-gamma and NO overproduction. International Journal of Neurology Research 2015; 1:102-122. [CrossRef]

32. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154:357-365. [CrossRef]

33. Asci Z, Akgun S. The evaluation of toxoplasma gondii (T.gondii) serology results among cases who admitted to the serology laboratory of a hospital in afyon city. Turkiye Parazitol Derg 2015: 39:9-12. (Turkish) [CrossRef]

34. Boluk S, Ozyurt BC, Girginkardesler N, Kilimcioğlu AA. Evaluation of serological results of patients with suspected Toxoplasmosis admitted to the medical parasitology laboratory of Celal Bayar University Hospital between 2006-2010. Turkiye Parazitol Derg 2012; 36:137-141. (Turkish) [CrossRef]

35. Iraz M, Gultepe B, Ceylan A, Doymaz MZ. Seroprevalence of toxoplasma and rubella in childbearing age women. Abant Medical Journal 2015; 4:11-14. (Turkish) [CrossRef]

36. Okur M. Van Gölü havzasında 0–18 yaş grubu çocuklarda Sitomegalovirus, Rubella ve Toksoplazma seroprevalansı. Konuralp Tip Dergisi 2012; 4:13-16. (Turkish)

37. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol 2011; 9:e1001081. [CrossRef]

38. Abdoli A, Dalimi A. Are there any relationships between latent Toxoplasma gondii infection, testosterone elevation, and risk of autism spectrum disorder? Front Behav Neurosci 2014; 8:339. [CrossRef]

39. Hodková H, Kolbeková P, Skallová A, Lindová J, Flegr J. Higher perceived dominance in Toxoplasma infected men--a new evidence for role of increased level of testosterone in toxoplasmosis-associated changes in human behavior. Neuro Endocrinol Lett 2007; 28:110-114.

40. Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254:4-8. [CrossRef]

41. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003; 62:237-244. [CrossRef]

Creative Commons Lisansı

Dusunen Adam: The Journal of Psychiatry and Neurological Sciences is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi
Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi
Yerküre Tanıtım ve Yayıncılık Hizmetleri A.Ş.